Assignment of Patent Rights. If Employee, during the course of his or her employment with the Company, creates or discovers any patentable or potentially patentable invention or design, within the meaning of Title 35 of the United States Code, any utility or design patent that may be derived from any such invention or design created or discovered by Employee during the course of his or her employment with the Company shall be assigned to the Company. Employee agrees to fully cooperate with the Company in obtaining any such patents, and Employee further agrees to execute any and all documents the Company may deem necessary to obtain such patent or to document such assignment to the Company. Employee hereby designates the Company as his/her attorney-in-fact to execute any such documents relating to any such patent or assignment thereof to the Company;
Assignment of Patent Rights. (a) As requested by OSIRIS, CWRU shall sign and shall cause the applicable inventors to sign any and all documents and papers reasonably requested by OSIRIS to evidence and/or perfect the assignment to OSIRIS of Existing Patent Rights, including, but not limited to, those to be filed in patent offices in which Existing Patents are pending and/or from which Existing Patents have been granted. To the extent that Developed Patent Rights have been assigned by CWRU to OSIRIS (although not required by the Agreement), OSIRIS shall reassign such Developed Patent Rights to CWRU within 30 days of the Amendment Effective Date.
(b) CWRU shall own any Patent Application that is directed to an invention made by an employee(s) of CWRU during the week in which the invention was conceived other than claims relating to an Existing Patent Right. OSIRIS shall own any Patent Application that does not include Excluded Patent Rights, directed to an invention made by an employee of OSIRIS who was not also an employee of CWRU during the week in which the invention was conceived. Inventions made by an employee of OSIRIS, who was not also an employee of CWRU during the week in which the invention was conceived, and an employee of CWRU shall be owned jointly by OSIRIS and CWRU.
Assignment of Patent Rights. In connection with this Agreement, Xxxxxxx has assigned and transferred all of its and its Affiliates’ right, title and interest in and to certain patent rights to Xxxx X. Such assignment was formalized by the execution and delivery by Xxxxxxx to Rose U of an assignment in the form attached as Exhibit A-3 (the patents, applications and rights assigned pursuant thereto, the “Assigned Patent Applications”).
Assignment of Patent Rights. (a) The licenses granted to the members of the Freescale Group under Section 4.3(a) (License – IC Patent Claims), Section 4.3(b) (License – Motorola Wireless Patent Claims) and Section 4.3(c) (License – Development Systems) are assignable by Freescale only to the acquirer of all or substantially all of the assets of the SPS Business, and provided that: (i) all such licenses are assigned together (i.e., concurrently and to the same assignee); (ii) the assignee expressly assumes in writing acceptable to Motorola all obligations and limitations under this Agreement with respect to such licenses; and (iii) such assigned licenses may be exercised by the assignee only in connection with (A) the operation of the SPS Business, the Semiconductor Products and assets of Freescale so sold or disposed of, and (B) with the authorization or approval of any governmental authority as then may be required. Further, the rights and licenses in favor of the assignee will be the same as those as set forth in Section 9.2(a) as applicable, depending on whether the assignor remains a separately identifiable business.
(b) Freescale may not assign any of its rights or privileges under Section 4.4 (Motorola Customer Patent Covenants) or Section 4.3(d) (Covenant Not to Assert – Wireless Semiconductor Product) without the prior written consent of Motorola which consent may be withheld in its sole and absolute discretion. The covenants not to xxx as well as the rights and obligations of Section 4.4 (Motorola Customer Patent Covenants) and Section 4.3(d) (Covenant Not to Assert – Wireless Semiconductor Product) are personal and will not be assignable or transferable in the event of a Change of Control of Freescale (whether by operation of law or otherwise), without Motorola’s prior written consent, which consent may be withheld in its sole and absolute discretion.
(c) Any assignment or attempted assignment in violation of the foregoing will be null and void.
(d) If any member of the Motorola Group or Freescale Group, respectively, assigns to a third Person any Motorola Patent or Freescale Patent that is otherwise subject to any of the licenses or covenants set forth in Article 4 (Patent License and Non-Assert) then: (i) notwithstanding such assignment, such assigned Motorola Patent or Freescale Patent, as applicable, shall remain subject to the applicable licenses and covenants set forth in Article 4 (Patent License and Non-Assert); and (ii) the assigning party shall notify the third Per...
Assignment of Patent Rights. In consideration of the mutual obligations set forth in that Patent Purchase Agreement dated by and between NuVasive, Inc. ("NuVasive") and Drs. Xxxxxxx X. Xxxx and Xxxxx X. Xxxxxxxxx ("Drs. Xxxx and Xxxxxxxxx"), the adequacy and receipt of which is hereby acknowledged, Xx. Xxxx and Guagliano, owners of the entire right, title, and interest in and to U.S. Patent Nos. 6,183,518, 6,206,921 and 6,264,659 and US Patent Applications Ser. No. 09/659,807 and 09/990,174 ("Patent Rights") hereby sell and assign to NuVasive the entire right, title and interest in the Patent Rights, to be held and enjoyed by NuVasive, its successors and assigns, as fully and entirely as the same would have been held and enjoyed by Drs. Xxxx and Xxxxxxxxx had this assignment and sale not been made.
Assignment of Patent Rights a. Planet has executed and delivered to Agway an assignment of certain of the Patent Rights, including the Animal Feed Patent Rights, (the "Assignment") a copy of which Assignment is attached as Exhibit C; and Agway confirms that the Assignment has been recorded in the United States Patent and Trademark Office.
b. Planet confirms the assignment of the patents listed in the Assignment. Planet shall execute and deliver to Agway further assignments, in substantially the same form as the Assignment, of (i) any subsequent patent applications derived from current research initiatives related to the Products, not including products related to and/or incorporating lysine; and (ii) any international patent applications related to the Animal Feed Patent Rights.
c. Planet will execute all such further assignments and related documents, prepared by or for Agway, as may be reasonably necessary to secure to Agway its ownership of the Animal Feed Patent Rights throughout the world.
d. The parties acknowledge and agree that the assignment of the Animal Feed Patent Rights by Planet to Agway is final, and that no breach, termination or expiration of this Agreement and/or the License, or failure to pay royalties, shall invalidate the Assignment or cause or give rise to any claim for any reversion of the Patent Rights to Planet, provided, however, that Planet may reacquire the Animal Feed Patent Rights pursuant to Section 10a of this Agreement.
e. Planet hereby fully and forever releases and waives any agreement by Agway to grant to Planet an option to repurchase the Patent Rights. Nothing contained in the previous sentence shall be interpreted or construed as indicating that the parties ever entered into an agreement granting Planet an option to repurchase the Patent Rights.
Assignment of Patent Rights. Subject to the terms and conditions set forth in this Agreement, Assignor hereby sells, transfers, conveys and assigns to Assignee, and Assignee acquires and accepts from Assignor, all right, title, and interest in and to the Assigned Patents, including, without limitation, (a) all causes of action and other enforcement rights for damages, injunctive relief, restitution, and any other remedies of any kind whether at law or in equity, whether accruing before, on or after the Assignment Date, for past, current, and future infringement, misappropriation, violation, breach or default, subject to the terms and conditions of this Agreement including without limitation the Existing Encumbrances, (b) all royalties, fees, income, payments, and other proceeds now or hereafter due or payable, other than the Existing Encumbrances, (c) the inventions, invention disclosures, and discoveries claimed in any of the Assigned Patents, (d) all other rights, privileges and protections of any kind whatsoever accruing under any of the foregoing rights listed in subclauses (a),(b), and (c) above as provided by any applicable law, treaty or other international convention throughout the world (collectively, the “Assignment”).
Assignment of Patent Rights. Glaxo Group Limited, a company incorporated under the laws of England and Wales with offices at Glaxo Xxxxxxxx Xxxxx, Xxxxxxxx Xxxxxx, Xxxxxxxxx, Xxxxxxxxx, XX0 0XX Xxxxxxx (“GGL”) and SmithKline Xxxxxxx Corporation d/b/a GlaxoSmithKline, a company incorporated under the laws of the Commonwealth of Pennsylvania with offices at One Franklin Plaza, 000 Xxxxx 00xx Xxxxxx, Xxxxxxxxxxxx, Xxxxxxxxxxxx 00000 X.X.X. (“SB”) (GGL and SB are collectively referred to in this Assignment as “Assignor”), hereby assign certain patent rights to Jazz Pharmaceuticals, Inc., a company incorporated under the laws of the State of Delaware with offices at 000 Xxxxxx Xxx, Palo Alto, California 94304 (“Assignee”).
Assignment of Patent Rights. Assignor and Assignee hereby agree that this Exhibit 1 shall be identical to Schedule A to the Agreement. Assignee shall have the right to prepare multiple versions of this Exhibit 1 that list one or more of the Patents for a single country set forth on Schedule A for recordation with the appropriate governmental authority of such country.
Assignment of Patent Rights. ProMab agrees to sell and assign, and hereby does sell and assign, to Caribou all rights, title, and interest in the Assigned Patent Rights, including but not limited to enforcement rights and rights to future inventions or improvements derived from the Assigned Patent Rights. No rights or interest of any kind in the Assigned Patent Rights are retained by ProMab.
